Estimate Recalculated Jun 3, 2025 08:09PM EST
Matthew Strobeck has an estimated net worth of $3.17 Million. This is based on reported shares across multiple companies, which include QUIDEL CORP /DE/, ELUTIA INC., METABOLIX, INC., Accelerate Diagnostics, Inc, BIODESIX INC, QuidelOrtho Corp, and SANTARUS INC.
Matthew Strobeck's CIK is 0001377832
2022 was Matthew Strobeck's most active year for acquiring shares with 13 total transactions. Matthew Strobeck's most active month to acquire stocks was the month of April. 2020 was Matthew Strobeck's most active year for disposing of shares, totalling 11 transactions. Matthew Strobeck's most active month to dispose stocks was the month of April. 2020 saw Matthew Strobeck paying a total of $1,503,703.91 for 998,428 shares, this is the most they've acquired in one year. In 2020 Matthew Strobeck cashed out on 5,094,500 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!